Global Steroid Compounds 麻豆原创 Research Report 2024

Publication ID:

PB508249107

Publication Date:

August 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Steroidal compounds are听solid alcohols that shoulder very important biological functions in the cells, which are widely distributed in plants, animals and fungi. The types of nature organic compounds found in plants are termed plant steroids.
The global Steroid Compounds market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Steroid Compounds is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Steroid Compounds is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Steroid Compounds include Pfizer, Alfa Chemistry, Chemenu, Tocris Bioscience, Centurion Healthcare, BOC Sciences, Hubei Pharmaceutical Group, BIOFOUNT and Zhejiang Xianju Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Steroid Compounds, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Steroid Compounds.
Report Scope
The Steroid Compounds market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Steroid Compounds market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Steroid Compounds manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Pfizer
Alfa Chemistry
Chemenu
Tocris Bioscience
Centurion Healthcare
BOC Sciences
Hubei Pharmaceutical Group
BIOFOUNT
Zhejiang Xianju Pharmaceutical
Shandong Sito Bio-Technology
Shanghai Shize Biotechnology
BioBioPha
Beijing Baiao Leibo Technology
Zizhu Pharmaceutical
Henan Steroids Biotechnology
Segment by Type
C18 Steroids
C19 Steroids
C21 Steroids
C24 Steroids
Others
Segment by Application
Medicine
Agriculture
Animal Husbandry
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Steroid Compounds manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Steroid Compounds in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Steroid Compounds 麻豆原创 Overview
1.1 Product Overview and Scope of Steroid Compounds
1.2 Steroid Compounds Segment by Type
1.2.1 Global Steroid Compounds 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 C18 Steroids
1.2.3 C19 Steroids
1.2.4 C21 Steroids
1.2.5 C24 Steroids
1.2.6 Others
1.3 Steroid Compounds Segment by Application
1.3.1 Global Steroid Compounds 麻豆原创 Value by Application: (2024-2030)
1.3.2 Medicine
1.3.3 Agriculture
1.3.4 Animal Husbandry
1.3.5 Others
1.4 Global Steroid Compounds 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Steroid Compounds Revenue 2019-2030
1.4.2 Global Steroid Compounds Sales 2019-2030
1.4.3 Global Steroid Compounds 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Steroid Compounds 麻豆原创 Competition by Manufacturers
2.1 Global Steroid Compounds Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Steroid Compounds Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Steroid Compounds Average Price by Manufacturers (2019-2024)
2.4 Global Steroid Compounds Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Steroid Compounds, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Steroid Compounds, Product Type & Application
2.7 Steroid Compounds 麻豆原创 Competitive Situation and Trends
2.7.1 Steroid Compounds 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Steroid Compounds Players 麻豆原创 Share by Revenue
2.7.3 Global Steroid Compounds 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Steroid Compounds Retrospective 麻豆原创 Scenario by Region
3.1 Global Steroid Compounds 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Steroid Compounds Global Steroid Compounds Sales by Region: 2019-2030
3.2.1 Global Steroid Compounds Sales by Region: 2019-2024
3.2.2 Global Steroid Compounds Sales by Region: 2025-2030
3.3 Global Steroid Compounds Global Steroid Compounds Revenue by Region: 2019-2030
3.3.1 Global Steroid Compounds Revenue by Region: 2019-2024
3.3.2 Global Steroid Compounds Revenue by Region: 2025-2030
3.4 North America Steroid Compounds 麻豆原创 Facts & Figures by Country
3.4.1 North America Steroid Compounds 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Steroid Compounds Sales by Country (2019-2030)
3.4.3 North America Steroid Compounds Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Steroid Compounds 麻豆原创 Facts & Figures by Country
3.5.1 Europe Steroid Compounds 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Steroid Compounds Sales by Country (2019-2030)
3.5.3 Europe Steroid Compounds Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Steroid Compounds 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Steroid Compounds 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Steroid Compounds Sales by Country (2019-2030)
3.6.3 Asia Pacific Steroid Compounds Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Steroid Compounds 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Steroid Compounds 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Steroid Compounds Sales by Country (2019-2030)
3.7.3 Latin America Steroid Compounds Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Steroid Compounds 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Steroid Compounds 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Steroid Compounds Sales by Country (2019-2030)
3.8.3 Middle East and Africa Steroid Compounds Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Steroid Compounds Sales by Type (2019-2030)
4.1.1 Global Steroid Compounds Sales by Type (2019-2024)
4.1.2 Global Steroid Compounds Sales by Type (2025-2030)
4.1.3 Global Steroid Compounds Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Steroid Compounds Revenue by Type (2019-2030)
4.2.1 Global Steroid Compounds Revenue by Type (2019-2024)
4.2.2 Global Steroid Compounds Revenue by Type (2025-2030)
4.2.3 Global Steroid Compounds Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Steroid Compounds Price by Type (2019-2030)
5 Segment by Application
5.1 Global Steroid Compounds Sales by Application (2019-2030)
5.1.1 Global Steroid Compounds Sales by Application (2019-2024)
5.1.2 Global Steroid Compounds Sales by Application (2025-2030)
5.1.3 Global Steroid Compounds Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Steroid Compounds Revenue by Application (2019-2030)
5.2.1 Global Steroid Compounds Revenue by Application (2019-2024)
5.2.2 Global Steroid Compounds Revenue by Application (2025-2030)
5.2.3 Global Steroid Compounds Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Steroid Compounds Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Steroid Compounds Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Alfa Chemistry
6.2.1 Alfa Chemistry Corporation Information
6.2.2 Alfa Chemistry Description and Business Overview
6.2.3 Alfa Chemistry Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alfa Chemistry Steroid Compounds Product Portfolio
6.2.5 Alfa Chemistry Recent Developments/Updates
6.3 Chemenu
6.3.1 Chemenu Corporation Information
6.3.2 Chemenu Description and Business Overview
6.3.3 Chemenu Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chemenu Steroid Compounds Product Portfolio
6.3.5 Chemenu Recent Developments/Updates
6.4 Tocris Bioscience
6.4.1 Tocris Bioscience Corporation Information
6.4.2 Tocris Bioscience Description and Business Overview
6.4.3 Tocris Bioscience Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tocris Bioscience Steroid Compounds Product Portfolio
6.4.5 Tocris Bioscience Recent Developments/Updates
6.5 Centurion Healthcare
6.5.1 Centurion Healthcare Corporation Information
6.5.2 Centurion Healthcare Description and Business Overview
6.5.3 Centurion Healthcare Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Centurion Healthcare Steroid Compounds Product Portfolio
6.5.5 Centurion Healthcare Recent Developments/Updates
6.6 BOC Sciences
6.6.1 BOC Sciences Corporation Information
6.6.2 BOC Sciences Description and Business Overview
6.6.3 BOC Sciences Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BOC Sciences Steroid Compounds Product Portfolio
6.6.5 BOC Sciences Recent Developments/Updates
6.7 Hubei Pharmaceutical Group
6.6.1 Hubei Pharmaceutical Group Corporation Information
6.6.2 Hubei Pharmaceutical Group Description and Business Overview
6.6.3 Hubei Pharmaceutical Group Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hubei Pharmaceutical Group Steroid Compounds Product Portfolio
6.7.5 Hubei Pharmaceutical Group Recent Developments/Updates
6.8 BIOFOUNT
6.8.1 BIOFOUNT Corporation Information
6.8.2 BIOFOUNT Description and Business Overview
6.8.3 BIOFOUNT Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BIOFOUNT Steroid Compounds Product Portfolio
6.8.5 BIOFOUNT Recent Developments/Updates
6.9 Zhejiang Xianju Pharmaceutical
6.9.1 Zhejiang Xianju Pharmaceutical Corporation Information
6.9.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.9.3 Zhejiang Xianju Pharmaceutical Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zhejiang Xianju Pharmaceutical Steroid Compounds Product Portfolio
6.9.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.10 Shandong Sito Bio-Technology
6.10.1 Shandong Sito Bio-Technology Corporation Information
6.10.2 Shandong Sito Bio-Technology Description and Business Overview
6.10.3 Shandong Sito Bio-Technology Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shandong Sito Bio-Technology Steroid Compounds Product Portfolio
6.10.5 Shandong Sito Bio-Technology Recent Developments/Updates
6.11 Shanghai Shize Biotechnology
6.11.1 Shanghai Shize Biotechnology Corporation Information
6.11.2 Shanghai Shize Biotechnology Steroid Compounds Description and Business Overview
6.11.3 Shanghai Shize Biotechnology Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai Shize Biotechnology Steroid Compounds Product Portfolio
6.11.5 Shanghai Shize Biotechnology Recent Developments/Updates
6.12 BioBioPha
6.12.1 BioBioPha Corporation Information
6.12.2 BioBioPha Steroid Compounds Description and Business Overview
6.12.3 BioBioPha Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BioBioPha Steroid Compounds Product Portfolio
6.12.5 BioBioPha Recent Developments/Updates
6.13 Beijing Baiao Leibo Technology
6.13.1 Beijing Baiao Leibo Technology Corporation Information
6.13.2 Beijing Baiao Leibo Technology Steroid Compounds Description and Business Overview
6.13.3 Beijing Baiao Leibo Technology Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Beijing Baiao Leibo Technology Steroid Compounds Product Portfolio
6.13.5 Beijing Baiao Leibo Technology Recent Developments/Updates
6.14 Zizhu Pharmaceutical
6.14.1 Zizhu Pharmaceutical Corporation Information
6.14.2 Zizhu Pharmaceutical Steroid Compounds Description and Business Overview
6.14.3 Zizhu Pharmaceutical Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zizhu Pharmaceutical Steroid Compounds Product Portfolio
6.14.5 Zizhu Pharmaceutical Recent Developments/Updates
6.15 Henan Steroids Biotechnology
6.15.1 Henan Steroids Biotechnology Corporation Information
6.15.2 Henan Steroids Biotechnology Steroid Compounds Description and Business Overview
6.15.3 Henan Steroids Biotechnology Steroid Compounds Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Henan Steroids Biotechnology Steroid Compounds Product Portfolio
6.15.5 Henan Steroids Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Steroid Compounds Industry Chain Analysis
7.2 Steroid Compounds Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Steroid Compounds Production Mode & Process
7.4 Steroid Compounds Sales and 麻豆原创ing
7.4.1 Steroid Compounds Sales Channels
7.4.2 Steroid Compounds Distributors
7.5 Steroid Compounds Customers
8 Steroid Compounds 麻豆原创 Dynamics
8.1 Steroid Compounds Industry Trends
8.2 Steroid Compounds 麻豆原创 Drivers
8.3 Steroid Compounds 麻豆原创 Challenges
8.4 Steroid Compounds 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Alfa Chemistry
Chemenu
Tocris Bioscience
Centurion Healthcare
BOC Sciences
Hubei Pharmaceutical Group
BIOFOUNT
Zhejiang Xianju Pharmaceutical
Shandong Sito Bio-Technology
Shanghai Shize Biotechnology
BioBioPha
Beijing Baiao Leibo Technology
Zizhu Pharmaceutical
Henan Steroids Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.